USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Qualimed Innovative Medizinprodukte GbmH

USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Qualimed ranks #21,652 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.

#21,652
of 49,997 US assignees by volume
17th percentile
by Innovation Score (25.4/100)
15.3
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21652 · Foreign Corporation #21,652 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,652/49,997
  • PHOTO-FINISH Qingdao Kingagroot…
  • CPC-NARROW A61B · 4 areas
  • INNOV-THIN 25.4/100
  • CLAIMS-RICH 15.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Qingdao Kingagroot Chemical Compound Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Qualimed’s 25.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Qualimed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Qualimed's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Qualimed?

Each dot is one of Qualimed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Qualimed’s own 15.3 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Qualimed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 101520253035 Granted patents (volume) Avg claims / patent Qognify, Ltd. - 13, 18.62QognifyQuantum Base Limited - 13, 19.38Quantum BaseQxonix Inc. - 13, 31.31QxonixQingdao Kingagroot Chemical Compound Co., Ltd. - 13, 14.23Qingdao Kingagroo…QuantumZ Inc. - 13, 13.85QuantumzQuick Vault, Inc. - 13, 19.15Quick VaultQuidnet Energy Inc. - 13, 12.08Quidnet EnergyR.A. Miller Industries, Inc. - 13, 12.62R A Miller Indust…Qualimed Innovative Medizinprodukte GbmH - 13, 15.31Qualimed Innovati…
Qualimed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Qualimed's grants concentrate

Qualimed Innovative Medizinprodukte GbmH is a focused PatentsView assignee: 4 CPC subclasses with 92.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2019. By volume, Qualimed sits between Qognify, Ltd. and R.A. Miller Industries, Inc..

Who files at Qualimed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Qualimed holds 13 patents at rank #21,650, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Qualimed

By rank, the assignees closest to #21,650 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Qualimed's primary technology class.

Qualimed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201520162018201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Qualimed Innovative Medizinprodukte GbmH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 23.1%
2016 3 23.1%
2018 4 30.8%
2019 1 7.7%
2020 1 7.7%
2021 1 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Qualimed Innovative Medizinprodukte GbmH's patent record in context - here's where to go next.

  • Qualimed Innovative Medizinprodukte GbmH's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 92.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #21,652 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Qualimed Innovative Medizinprodukte GbmH against Qognify, Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.